Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
This nine-digit number identifies your bank or credit union in a financial transaction. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback